CAMP and atherosclerosis: Recent studies have indeed raised concerns about the pleiotropic effect of e2e2 that warrant further investigations.[32, 33, 34] CAMP is an antimicrobial protein linked to the innate immune system with a documented role in atherosclerosis.[35] In our analysis, e2e2 carriers had 87% increased level of CAMP compared to e3e3 carriers (p_adj = 1.83E‐6).